Oxford/AstraZeneca vaccine 80% effective against B1.617.2 variant of COVID-19: UK govt study

The Oxford/AstraZeneca two-dose vaccine is also being produced by the Serum Institute of India as Covishield and being administered among the adult population in India to protect against the deadly virus.

from Zee News :India National https://ift.tt/3vNmqr2